Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019045989) METHODS AND COMPOSITIONS FOR THE ANTIVIRAL USE OF SYNTHETIC LYSINE ANALOGS AND MIMETICS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/045989 International Application No.: PCT/US2018/046023
Publication Date: 07.03.2019 International Filing Date: 09.08.2018
IPC:
A61K 31/195 (2006.01) ,A61K 39/40 (2006.01) ,G01N 33/53 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
185
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
19
Carboxylic acids, e.g. valproic acid
195
having an amino group
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
395
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
40
bacterial
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
50
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53
Immunoassay; Biospecific binding assay; Materials therefor
Applicants:
ANTI-PLASMIN TECHNOLOGIES, LLC [US/US]; 5526 Stonegate Road Dallas, TX 7509-3522, US
Inventors:
MURDOCK, Frank; US
MURDOCK, Ronnea; US
STEWART, W., Paul; US
Agent:
GOPALAKRISHNAN, Lekha; US
UDOVICH, Samuel, A.; US
LOVELL, David, A.; US
MOORE, Stanley, R.; US
MOON, Wiilliam, Allen; US
THOMAS, Daniel, A.; US
Priority Data:
62/550,65627.08.2017US
62/664,55530.04.2018US
Title (EN) METHODS AND COMPOSITIONS FOR THE ANTIVIRAL USE OF SYNTHETIC LYSINE ANALOGS AND MIMETICS
(FR) MÉTHODES ET COMPOSITIONS POUR L'UTILISATION ANTIVIRALE D'ANALOGUES ET DE MIMÉTIQUES SYNTHÉTIQUES DE LYSINE
Abstract:
(EN) A method for treatment, prevention, or reduction of one-time or recurring viral outbreaks, for suppression of development or growth of chronic viral infections, or for prevention or treatment of viral infections, the method including, administering a synthetic lysine analog or mimetic, where the synthetic lysine analog or mimetic antagonizes or competes with an amino acid or other biological agent required by a virus to replicate or spread. Additionally, a composition to treat, prevent, or reduce one-time or recurrent viral outbreaks, suppress development or growth of chronic viral infections, or to prevent or treat viral infections, the composition including, a synthetic lysine analog or mimetic, where the synthetic lysine analog or mimetic antagonizes or competes with an amino acid or other biological agent required by a virus to replicate or spread.
(FR) L'invention concerne une méthode pour le traitement, la prévention ou la réduction des épidémies virales ponctuelles ou récurrentes, pour la suppression du développement ou de la croissance d'infections virales chroniques, ou pour la prévention ou le traitement d'infections virales, la méthode comprenant l'administration d'un analogue ou d'un mimétique synthétique de lysine, l'analogue ou le mimétique synthétique de lysine antagonise ou entre en concurrence avec un acide aminé ou avec un autre agent biologique requis par un virus pour se répliquer ou s'étaler. L'invention concerne également une composition pour traiter, prévenir ou réduire des épidémies virales ponctuelles ou récurrentes, supprimer le développement ou la croissance d'infections virales chroniques, ou pour prévenir ou traiter des infections virales, la composition comprenant, un analogue ou un mimétique synthétique de lysine, l'analogue ou le mimétique synthétique de lysine antagonise ou entre en concurrence avec un acide aminé ou avec un autre agent biologique requis par un virus pour se répliquer ou s'étaler.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)